Such manipulation of Csk activity by small molecule inhibitors could be useful therapeutically, for example in pathologic settings where suppression (i.e., autoimmunity) or augmentation (i.e., vaccines or cancer) of T cell responses to antigen is desirable. Here, CSK is linked to cancer.